Kinetics of primidone metabolism and excretion in children
- 1 August 1977
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 22 (2) , 200-205
- https://doi.org/10.1002/cpt1977222200
Abstract
The metabolism and excretion of orally administered primidone was studied in 12 children, aged 7 to 14 yr during long‐term dosing. Plasma concentrations ofprimidone (Pr) peaked at 4 to 6 hr and declined exponentially from 6 to 24 hr, with half‐life (t½) values ranging from 4.5 to 11 hr. A mean of 92% (72% to 123%) of the administered dose was recovered within 24 hr from the urine as Pr and its metabolites. Of the total Pr daily dose, 42.3% (15.2% to 65.9%) was recovered as unchanged drug, 45.2% (16.3% to 65.3%) as phenylethylmalonamide (PEMA), and 4.9% (1.1% to 8.0%) as phenobarbital (Pb). The mean rate constant for conversion of Pr to PEMA (K J was 0.0424 hr‐1, for conversion of Pr to Pb (Kz) was 0.0045 hr:', and for excretion of unchanged Pr (K3) was 0.0389 hr‐1 Of the Pb excreted, 43% (13% to 100%) was unchanged, 15% (0% to 27%) was unconjugated p‐OH Pb, 20% (0% to 44%) was conjugated p‐OH Pb, and 22% (0% to 33%) was conjugated 3,4‐0H Pb.,appears to be an important determinant of the steady‐state plasma concentration of Pb, but interindividual differences in Kz have little influence on the overall rate constant [or elimination of Pr.This publication has 3 references indexed in Scilit:
- The relation between primidone and phenobarbitone blood levelsJournal of Pharmacy and Pharmacology, 1968
- THE METABOLIC CONVERSION OF PRIMIDONE (MYSOLINE®) TO PHENOBARBITONE IN PATIENTS UNDER LONG-TERM TREATMENTActa Neurologica Scandinavica, 1967
- Metabolic Conversion of Primidone (Mysoline) to Phenobarbital.Experimental Biology and Medicine, 1956